RIL
ADMA icon

Rothschild Investment LLC’s ADMA Biologics ADMA Stock Holding History

Rothschild Investment LLC’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7K Sell
1,762
-598
-25% -$5.45K ﹤0.01% 1685
2026
Q1 		$21.3K Buy
2,360
+177
+8% +$2.79K ﹤0.01% 1397
2025
Q4 		$39.8K Buy
2,183
+288
+15% +$4.85K ﹤0.01% 1094
2025
Q3 		$27.8K Buy
1,895
+1,495
+374% +$25.6K ﹤0.01% 1157
2025
Q2 		$7.28K Buy
400
+15
+4% +$306 ﹤0.01% 1341
2025
Q1 		$7.64K Buy
385
+180
+88% +$3.11K ﹤0.01% 1258
2024
Q4 		$3.52K Sell
205
-30
-13% -$564 ﹤0.01% 1490
2024
Q3 		$4.7K Buy
235
+135
+135% +$2.1K ﹤0.01% 1320
2024
Q2 		$1.12K Buy
100
+80
+400% +$671 ﹤0.01% 1602
2024
Q1 		$132 Buy
+20
New +$109 ﹤0.01% 2009

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Rothschild Investment LLC's ADMA Position: Q2 2026 in Review

Rothschild Investment LLC reduced its ADMA Biologics (ADMA) stake by 25% in Q2 2026, selling an estimated $5.45K and leaving 1,762 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1685.

Rothschild Investment LLC first reported a position in ADMA in Q1 2024 and has held it in 10 quarters since. The position peaked at $39.8K in Q4 2025. 131 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Rothschild Investment LLC held 1,762 shares of ADMA Biologics worth $14.7K as of Q2 2026.
  • Rothschild Investment LLC sold 598 ADMA Biologics shares in Q2 2026, an estimated $5.45K.
  • ADMA Biologics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1685 holding.
  • Rothschild Investment LLC first reported a position in ADMA Biologics in Q1 2024 and has held it in 10 quarters since.
  • Rothschild Investment LLC's ADMA Biologics position peaked at $39.8K in Q4 2025.
  • 131 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.